These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16417649)

  • 1. New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines.
    Crowe DL; Lee MK
    Breast Cancer Res; 2006; 8(1):R1. PubMed ID: 16417649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p300 Modulates the BRCA1 inhibition of estrogen receptor activity.
    Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
    Cancer Res; 2002 Jan; 62(1):141-51. PubMed ID: 11782371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coactivator-mediated estrogen response in human squamous cell carcinoma lines.
    Ku TK; Crowe DL
    J Endocrinol; 2007 Apr; 193(1):147-55. PubMed ID: 17400812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage.
    Dubrovska A; Kanamoto T; Lomnytska M; Heldin CH; Volodko N; Souchelnytskyi S
    Oncogene; 2005 Mar; 24(14):2289-97. PubMed ID: 15735739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
    Dutertre M; Smith CL
    Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators.
    Jaber BM; Gao T; Huang L; Karmakar S; Smith CL
    Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
    Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
    Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles of BRCA1 in transcriptional regulation and DNA repair.
    Chen Y; Lee WH; Chew HK
    J Cell Physiol; 1999 Dec; 181(3):385-92. PubMed ID: 10528224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.
    Bau DT; Fu YP; Chen ST; Cheng TC; Yu JC; Wu PE; Shen CY
    Cancer Res; 2004 Jul; 64(14):5013-9. PubMed ID: 15256476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
    Kazmi SM; Plante RK; Visconti V; Lau CY
    Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
    Wang H; Zeng ZC; Bui TA; DiBiase SJ; Qin W; Xia F; Powell SN; Iliakis G
    Cancer Res; 2001 Jan; 61(1):270-7. PubMed ID: 11196174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.
    Fan S; Wang JA; Yuan RQ; Ma YX; Meng Q; Erdos MR; Brody LC; Goldberg ID; Rosen EM
    Oncogene; 1998 Jun; 16(23):3069-82. PubMed ID: 9662340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine disrupting chemicals may deregulate DNA repair through estrogen receptor mediated seizing of CBP/p300 acetylase.
    Lakshmanan MD; Shaheer K
    J Endocrinol Invest; 2020 Sep; 43(9):1189-1196. PubMed ID: 32253726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
    Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
    Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.
    Fritah A; Saucier C; Mester J; Redeuilh G; Sabbah M
    Mol Cell Biol; 2005 Mar; 25(6):2419-30. PubMed ID: 15743834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid.
    Sheikh MS; Shao ZM; Chen JC; Hussain A; Jetten AM; Fontana JA
    J Cell Biochem; 1993 Dec; 53(4):394-404. PubMed ID: 8300756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.